TrialThe lancet. HIV2020

Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial.

Punnee Pitisuttithum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.